TY - JOUR
T1 - Estimated pulse wave velocity is associated with residual-specific mortality
T2 - Findings from the National Health and Nutrition Examination Survey
AU - Heffernan, Kevin S.
AU - Jae, Sae Young
AU - Loprinzi, Paul D.
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Introduction:Estimated pulse wave velocity (ePWV) is emerging as a predictor of cardiovascular and all-cause mortality. Approximately one-Third of all deaths are not related to the top nine causes of mortality as defined by the CDC. We examined the association of ePWV with residual-specific mortality in a large sample of US adults.Methods:Data from the 1999-2006 National Health and Nutrition Examination Survey (NHANES) were used (n = 13 909 adults between the ages of 18-85 years), with follow-up through 2011 (mean follow-up, 104 months). ePWV was calculated from a regression equation using age and mean blood pressure.Results:After adjusting for age, pulse pressure, race/ethnicity, blood lipids, glucose, C-reactive protein, eGFR, smoking, self-reported physical activity, history of hypertension and diabetes, for every 1 m/s increase in ePWV, there was a 17% increased risk of residual-specific mortality (hazard ratio = 1.17, 95% CI = 1.02-1.36; P = 0.03). If using a previously recommended clinical cut-point of 10 m/s, those with an elevated ePWV had an increased risk of 57% (hazard ratio = 1.57; 95% CI = 0.98-2.50; P = 0.06).Conclusion:ePWV is associated with residual-specific mortality in a nationally representative sample of adults.
AB - Introduction:Estimated pulse wave velocity (ePWV) is emerging as a predictor of cardiovascular and all-cause mortality. Approximately one-Third of all deaths are not related to the top nine causes of mortality as defined by the CDC. We examined the association of ePWV with residual-specific mortality in a large sample of US adults.Methods:Data from the 1999-2006 National Health and Nutrition Examination Survey (NHANES) were used (n = 13 909 adults between the ages of 18-85 years), with follow-up through 2011 (mean follow-up, 104 months). ePWV was calculated from a regression equation using age and mean blood pressure.Results:After adjusting for age, pulse pressure, race/ethnicity, blood lipids, glucose, C-reactive protein, eGFR, smoking, self-reported physical activity, history of hypertension and diabetes, for every 1 m/s increase in ePWV, there was a 17% increased risk of residual-specific mortality (hazard ratio = 1.17, 95% CI = 1.02-1.36; P = 0.03). If using a previously recommended clinical cut-point of 10 m/s, those with an elevated ePWV had an increased risk of 57% (hazard ratio = 1.57; 95% CI = 0.98-2.50; P = 0.06).Conclusion:ePWV is associated with residual-specific mortality in a nationally representative sample of adults.
KW - National Health and Nutrition Examination Survey
KW - epidemiology
KW - survival
KW - vascular stiffness
UR - http://www.scopus.com/inward/record.url?scp=85102538223&partnerID=8YFLogxK
U2 - 10.1097/HJH.0000000000002691
DO - 10.1097/HJH.0000000000002691
M3 - Article
C2 - 33186319
AN - SCOPUS:85102538223
SN - 0263-6352
VL - 39
SP - 698
EP - 702
JO - Journal of Hypertension
JF - Journal of Hypertension
IS - 4
ER -